Powered by
ANN ARBOR—Celsee Inc., the single-cell isolation and analysis developer, announced an agreement to provide scientists at China’s Kindstar Global, a medical testing service,with Celsee’s Genesis System for monitoring circulating tumor …
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, announced that it has raised $22.2 million in a Preferred …
ANN ARBOR—An Ann Arbor company that has developed a system to screen cancer patients to precision-designed treatments that will be most effective for them has a new clinical development collaboration …
ANN ARBOR—Strata Oncology, a developer of cancer testing technology for hospitals and the pharmaceutical industry, announced the launch of version 3.0 of StrataNGS, its pan-cancer assay for solid tumors. The …
HOUGHTON – Determining the presence of cancer, as well as its type and malignancy, is a time-consuming process – patients can wait up to two stressful weeks for a diagnosis. …